Clinical Trial Update: Biological Response to Tamoxifen (TAM) in Patients With Breast Cancer Non Metastatic RH+ [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating biological response to tamoxifen in patients with non-metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer Non-metastatic

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: Institut Cancerologie de l'Ouest | Conditions: Non Metastatic Breast Cancer | Phase 2 | Status: COMPLETED